Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-11

Clinical Trial Update: Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

View source ↗

Summary

A clinical trial investigating the involvement of B lymphocytes in amyotrophic lateral sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Amyotrophic Lateral Sclerosis | Status: WITHDRAWN